- Issuer ticker
-
HEPA
- Reported as of
-
29 Sep 2026
- Net transaction value
-
+$10,000
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
02 Oct 2026, 16:30:28 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Danina Fisher
Key filing fact
Danina Fisher filed Form 4 for Hepion Pharmaceuticals, Inc. (HEPA) on 02 Oct 2026.
Key facts
- This page summarizes Danina Fisher's Form 4 filing for Hepion Pharmaceuticals, Inc. (HEPA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Oct 2026, 16:30.
Change
- Previous filing in this sequence was filed on 21 Aug 2026.
- Current net transaction value: +$10,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002144035
Primary reporting owner
Fisher Danina
- Relationship
-
Director
- Address
- C/O HEPION PHARMACEUTICALS, INC., 34 SHREWSBURY AVE., SUITE 1D, RED BANK,
- Signature
- /s/ Danina Fisher
- Signature date
- 02 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HEPA
transaction
Common Stock
Purchase
- Transaction value
- $10,000
- Shares
- +200,000
- Change %
- Price
-
$0.0500
- Shares after
- 200,000
- Date
- 29 Sep 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HEPA
transaction
Derivative
Warrants
Purchase
- Transaction value
- Shares
- +200,000
- Change %
- Price
-
$0.000000*
- Shares after
- 200,000
- Date
- 29 Sep 2026
- Ownership
- Direct
- Underlying class
- Commmon Stock
- Underlying amount
- 200,000
- Exercise price
- $0.0600
* marks a reported price that did not pass the local price check.